Thermo Fisher Scientific introduces AmpSure Universal SYBR Green and Probe Master Mixes, offering value-priced qPCR reagents.

Hepta reports its AI-based blood test matched MRE in identifying treatment-eligible MASH fibrosis in an independent Madrigal ...

Siemens Healthineers will separate its in vitro diagnostics business as Olyrian Diagnostics, aiming to complete the ...

Agilent has acquired digital pathology software firm Proscia for $240 million, adding an FDA-cleared platform to its ...

Bio-Rad adds new ddPCR assays, reagents and technologies for QX700 systems, expanding multiplex cancer mutation and biomarker ...

A study links early donor-derived cell-free DNA patterns to kidney transplant outcomes, including rejection and graft loss.

A study in Gynecologic Oncology reports that a Mercy BioAnalytics blood test measuring cancer-linked proteins may detect ...

A study found Lucid’s nonendoscopic EsoCheck device achieved a 95% sample collection rate for esophageal precancer testing in ...

FDA clears Cepheid’s Xpert Hemorrhagic Fever Panel, a multiplex PCR test for Ebola, Marburg, Lassa, and Crimean-Congo viruses ...

Pillar Biosciences introduces the MRDTect NPM1 and FLT3 ITD NGS panel for in-house acute myeloid leukemia MRD detection.

FDA clears Roche cobas eplex RP3 panel, which detects up to 19 respiratory pathogen and adds Bordetella pertussis.

A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.